Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.790
+0.020 (1.13%)
Jan 3, 2025, 4:00 PM EST - Market closed
MBRX's stock price has decreased by -87.09% in the past year and price targets may not have had time to catch up.
Moleculin Biotech Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$24.00
Upside
+1,240.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $20 → $8 | Strong Buy | Maintains | $20 → $8 | +346.93% | Nov 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +2,134.64% | Apr 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $20 | Strong Buy | Maintains | $45 → $20 | +1,017.32% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +2,413.97% | Dec 14, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $240 | Strong Buy | Maintains | $240 | +13,307.82% | Apr 18, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +4,089.94% | Mar 24, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $30 → $210 | Buy | Initiates | $30 → $210 | +11,631.84% | Jul 18, 2022 |